PubRank

William C Chapman

Author PubWeight™ 87.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004 2.13
2 Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria. Ann Surg 2016 2.05
3 Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 2004 1.77
4 Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 2012 1.70
5 Incorporation of a laser range scanner into image-guided liver surgery: surface acquisition, registration, and tracking. Med Phys 2003 1.52
6 Concepts and preliminary data toward the realization of image-guided liver surgery. J Gastrointest Surg 2007 1.50
7 Robust surface registration using salient anatomical features for image-guided liver surgery: algorithm and validation. Med Phys 2008 1.49
8 Compensating for intraoperative soft-tissue deformations using incomplete surface data and finite elements. IEEE Trans Med Imaging 2005 1.49
9 CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer 2006 1.44
10 Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 2010 1.40
11 Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival. Arch Surg 2002 1.24
12 The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Am Surg 2003 1.12
13 Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg 2006 1.11
14 Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. AJR Am J Roentgenol 2013 1.06
15 Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol 2005 1.06
16 Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection. Hum Immunol 2013 1.02
17 Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. J Am Coll Surg 2007 1.01
18 Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts. Liver Transpl 2011 1.00
19 Systemic nf-kappaB activation in a transgenic mouse model of acute pancreatitis. J Surg Res 2003 0.95
20 Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin. J Am Coll Surg 2009 0.95
21 Endotoxin potentiates lung injury in cerulein-induced pancreatitis. Am J Surg 2003 0.95
22 Hepatocellular carcinoma: a review of the surgical approaches to management. Mo Med 2011 0.94
23 Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis. J Virol 2014 0.94
24 SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases. Am J Surg Pathol 2014 0.94
25 Previously unreported high-grade complications of adrenalectomy. Surg Endosc 2008 0.93
26 Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis. Hum Immunol 2003 0.93
27 Elevated soluble CD30 correlates with development of bronchiolitis obliterans syndrome following lung transplantation. Transplantation 2006 0.93
28 Modulation of endotoxin-induced NF-kappa B activation in lung and liver through TNF type 1 and IL-1 receptors. Am J Physiol Lung Cell Mol Physiol 2002 0.93
29 Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res 2002 0.92
30 Registration of medical images using an interpolated closest point transform: method and validation. Med Image Anal 2004 0.92
31 Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway. PLoS One 2012 0.91
32 Advanced donor age alone does not affect patient or graft survival after liver transplantation. J Am Coll Surg 2008 0.89
33 Hepatic cryoablation-induced multisystem injury: bioluminescent detection of NF-kappaB activation in a transgenic mouse model. J Gastrointest Surg 2002 0.88
34 Ischemia-reperfusion injury in rat steatotic liver is dependent on NFκB P65 activation. Transpl Immunol 2012 0.88
35 Organ surface deformation measurement and analysis in open hepatic surgery: method and preliminary results from 12 clinical cases. IEEE Trans Biomed Eng 2011 0.87
36 Novel three-dimensional imaging technique improves the accuracy of hepatic volumetric assessment. HPB (Oxford) 2011 0.86
37 Role of intra-islet endothelial cells in islet allo-immunity. Transplantation 2007 0.86
38 Biliary strictures in pediatric liver transplant recipients - early diagnosis and treatment results in excellent graft outcomes. Pediatr Transplant 2009 0.86
39 Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis. Liver Transpl 2011 0.86
40 Short- and long-term outcomes after steatotic liver transplantation. Arch Surg 2010 0.85
41 Effects of hepatitis C virus infection and its recurrence after liver transplantation on functional performance and health-related quality of life. J Gastrointest Surg 2002 0.84
42 Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation. Transplantation 2011 0.84
43 Morbid obesity in liver transplant recipients adversely affects longterm graft and patient survival in a single-institution analysis. HPB (Oxford) 2014 0.84
44 Keratin 19 epithelial patterns in cirrhotic stroma parallel hepatocarcinogenesis. Am J Pathol 2011 0.84
45 Hepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosis. PLoS One 2013 0.84
46 Biliary reconstruction is enhanced with a collagen-polyethylene glycol sealant. Am Surg 2002 0.84
47 Hepatocellular carcinoma: resection versus transplantation. Semin Liver Dis 2013 0.83
48 Interleukin-1beta is the primary initiator of pulmonary inflammation following liver injury in mice. Am J Physiol Lung Cell Mol Physiol 2007 0.83
49 Liver transplantation for hepatocellular carcinoma: long-term results suggest excellent outcomes. J Am Coll Surg 2012 0.83
50 Outcomes with split liver transplantation are equivalent to those with whole organ transplantation. J Am Coll Surg 2013 0.82
51 Utilization of hepatitis B core antibody-positive donor liver grafts. HPB (Oxford) 2011 0.82
52 Characterization of inflammatory (lymphoepithelioma-like) hepatocellular carcinoma: a study of 8 cases. Arch Pathol Lab Med 2014 0.82
53 Liver transplantation for hepatocellular carcinoma: expanding special priority to include stage III disease. Arch Surg 2005 0.82
54 Do adverse histopathologic findings in colorectal cancer patients explain disparate outcomes? J Natl Med Assoc 2006 0.82
55 Chemoembolization of hepatocellular carcinoma: patient status at presentation and outcome over 15 years at a single center. AJR Am J Roentgenol 2008 0.81
56 Activation of nuclear factor kappa B and severe hepatic necrosis may mediate systemic inflammation in choline-deficient/ethionine-supplemented diet-induced pancreatitis. Pancreas 2006 0.81
57 Validation of organ procurement and transplant network (OPTN)/united network for organ sharing (UNOS) criteria for imaging diagnosis of hepatocellular carcinoma. Transplantation 2013 0.81
58 Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection. Hum Immunol 2003 0.81
59 Small bowel obstruction after pediatric liver transplantation: the unusual is the usual. J Am Coll Surg 2010 0.81
60 Conventional Surgical Treatment of Hepatocellular Carcinoma. Clin Liver Dis 2011 0.80
61 Interleukin-1beta is prominent in the early pulmonary inflammatory response after hepatic injury. Surgery 2005 0.80
62 MRI characterization of 124 CT-indeterminate focal hepatic lesions: evaluation of clinical utility. HPB (Oxford) 2007 0.79
63 Indications and limitations of liver transplantation for hepatocellular carcinoma. Surg Oncol Clin N Am 2003 0.78
64 Liver transplantation for unresectable metastases to the liver: a new era in transplantation or a time for caution? Ann Surg 2013 0.78
65 Transplantation for hepatocellular carcinoma: the North American experience. Recent Results Cancer Res 2013 0.78
66 Human immune responses to porcine endogenous retrovirus-derived peptides presented naturally in the context of porcine and human major histocompatibility complex class I molecules: implications in xenotransplantation of porcine organs. Transplantation 2004 0.78
67 Multi-organ inflammation after hepatic cryoablation in BALB/c mice. J Surg Res 2003 0.78
68 Hepatic hemangiopericytoma/solitary fibrous tumor: a review of our current understanding and case study. J Gastrointest Surg 2012 0.78
69 Liver transplantation and chemotherapy in children with unresectable primary hepatic malignancies: development of a management algorithm. J Pediatr Gastroenterol Nutr 2006 0.78
70 The role of molecular chaperonins in warm ischemia and reperfusion injury in the steatotic liver: a proteomic study. BMC Biochem 2012 0.78
71 Natural antibodies prevent in vivo transmission of porcine islet-derived endogenous retrovirus to human cells. Cell Transplant 2004 0.78
72 Parenchymal alterations in cirrhotic livers in patients with hepatopulmonary syndrome or portopulmonary hypertension. Liver Transpl 2013 0.77
73 Complement depletion enhances pulmonary inflammatory response after liver injury. J Gastrointest Surg 2006 0.77
74 CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model. Transplantation 2014 0.77
75 Water warming garment versus forced air warming system in prevention of intraoperative hypothermia during liver transplantation: a randomized controlled trial [ISRCTN32154832]. BMC Anesthesiol 2002 0.77
76 Radiofrequency ablation of recurrent hepatocellular carcinoma in a patient after liver transplantation: two-year follow-up. J Vasc Interv Radiol 2007 0.77
77 Using ALPPS to induce rapid liver hypertrophy in a patient with hepatic fibrosis and portal vein thrombosis. J Gastrointest Surg 2012 0.77
78 Temporal association between increased virus-specific Th17 response and spontaneous recovery from recurrent hepatitis C in a liver transplant recipient. Transplantation 2011 0.77
79 Delayed-onset cytomegalovirus disease coded during hospital readmission in a multicenter, retrospective cohort of liver transplant recipients. Liver Transpl 2015 0.77
80 No silver bullet in liver transection: what has 35 years of new technology added to liver surgery? Ann Surg 2009 0.77
81 Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients from the US Multicenter HCC Transplant Consortium. Ann Surg 2017 0.77
82 Topical recombinant human thrombin in surgical hemostasis. Semin Thromb Hemost 2010 0.76
83 Elevated soluble CD30 characterizes patients with hepatitis C virus-induced liver allograft cirrhosis. Transplantation 2007 0.76
84 Anonymous group peer review in surgery morbidity and mortality conference. Am J Surg 2009 0.76
85 Once weekly fluconazole for antifungal prophylaxis post-liver transplantation. HPB (Oxford) 2012 0.76
86 Management of excluded bile ducts in paediatric orthotopic liver transplant recipients of technical variant allografts. HPB (Oxford) 2011 0.76
87 Radiofrequency ablation for resectable colorectal hepatic metastases: is it time for a randomized controlled trial? Ann Surg 2010 0.75
88 Teach your children well: stage IV colorectal cancer and variability in practice patterns. Ann Surg Oncol 2012 0.75
89 Bouveret's syndrome complicated by classic gallstone ileus: progression of disease or iatrogenic? J Gastrointest Surg 2013 0.75
90 Liver volume in the cirrhotic patient: does size matter? Dig Dis Sci 2014 0.75
91 Perioperative blood transfusion affects hepatitis C virus (HCV)-specific immune responses and outcome following liver transplantation in HCV-infected patients. HPB (Oxford) 2013 0.75
92 Novel in vitro model for studying hepatic ischemia-reperfusion injury using liver cubes. Surgery 2012 0.75
93 Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival. Arch Surg 2008 0.75
94 Towards more effective liver allocation criteria for hepatocellular carcinoma: tumor response to locoregional therapy. Ann Surg Oncol 2011 0.75
95 Selection of patients for resection of hepatic colorectal metastases: expert consensus statement by Charnsangavej et al. Ann Surg Oncol 2006 0.75
96 High-risk liver transplant candidates: An ethical proposal on where to draw the line. Liver Transpl 2015 0.75
97 Fluorescent in situ hybridization testing in primary sclerosing cholangitis: useful testing or a random chance result? Hepatology 2010 0.75
98 Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody. Transplantation 2016 0.75
99 Incidental findings at surgery. Part 1. Curr Probl Surg 2008 0.75
100 Image of the month. Focal nodular hyperplasia. Arch Surg 2004 0.75
101 Incidental findings at surgery. Part 1. In brief. Curr Probl Surg 2008 0.75
102 Physician-Patient Communication is Associated With Hepatocellular Carcinoma Screening in Chronic Liver Disease Patients. J Clin Gastroenterol 2016 0.75
103 Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease. Ann Surg 2017 0.75
104 Topical use of recombinant human thrombin for operative hemostasis. Expert Opin Biol Ther 2009 0.75
105 Expert witness testimony: the problem and recommendations for oversight and reform. Surgery 2005 0.75
106 Response: "Which is the True Role of Bridging Therapies for HCC Patients Waiting for Liver Transplantation?" Ann Surg 2017 0.75
107 Liver transplantation for metastatic neuroendocrine tumors. Adv Surg 2014 0.75
108 Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results. Ann Surg 2017 0.75
109 Orthotopic liver transplant and hepatic resection: Lessons learned from complimentary disciplines. Curr Surg 2005 0.75
110 Positron emission tomography enhancing tumor thrombus in patient with renal cell carcinoma. Urology 2008 0.75
111 Organ allocation in pediatric renal transplants: is there an optimal donor? Clin Transplant 2013 0.75
112 Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort. Ann Surg 2017 0.75
113 Liver transplantation for hepatocellular carcinoma: current update on treatment and allocation. Curr Opin Organ Transplant 2016 0.75
114 Equalizing MELD Scores Over Broad Geographies Is Not the Most Efficacious Way to Allocate a Scarce Resource in a Value-based Environment. Ann Surg 2015 0.75